Inhaled Dry Powder Mannitol: A Solution for Cystic Fibrosis

被引:4
|
作者
Trapnell, Bruce C. [1 ]
机构
[1] Univ Cincinnati, Cincinnati Childrens Hosp Med Ctr, Cincinnati, OH USA
关键词
HYPERTONIC SALINE; CLEARANCE;
D O I
10.1164/rccm.201112-2205ED
中图分类号
R4 [临床医学];
学科分类号
1002 ; 100602 ;
摘要
引用
收藏
页码:596 / 598
页数:4
相关论文
共 50 条
  • [31] The use of inhaled mannitol in the diagnosis and management of asthma
    Sverrild, Asger
    Porsbjerg, Celeste
    Backer, Vibeke
    EXPERT OPINION ON PHARMACOTHERAPY, 2012, 13 (01) : 115 - 123
  • [32] Dornase alfa for cystic fibrosis
    Yang, Connie
    Montgomery, Mark
    COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2021, (03):
  • [33] The long term effect of inhaled hypertonic saline 6% in non-cystic fibrosis bronchiectasis
    Nicolson, Caroline H. H.
    Stirling, Robert G.
    Borg, Brigitte M.
    Button, Brenda M.
    Wilson, John W.
    Holland, Anne E.
    RESPIRATORY MEDICINE, 2012, 106 (05) : 661 - 667
  • [34] Cystic fibrosis
    Huegel, Christian
    Smaczny, Christina
    Eickmeier, Olaf
    Zielen, Stefan
    Rohde, Gernot
    PNEUMOLOGE, 2020, 17 (03): : 223 - 233
  • [35] Effects of inhaled hypertonic (7%) saline on lung function test in preschool children with cystic fibrosis: results of a crossover, randomized clinical trial
    Nenna, Raffaella
    Midulla, Fabio
    Lambiase, Caterina
    De Castro, Giovanna
    Zicari, Anna Maria
    Indinnimeo, Luciana
    Cimino, Giuseppe
    Troiani, Patrizia
    Quattrucci, Serena
    Tancredi, Giancarlo
    ITALIAN JOURNAL OF PEDIATRICS, 2017, 43
  • [36] Timing of dornase alfa inhalation for cystic fibrosis
    Dentice, Ruth
    Elkins, Mark
    COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2021, (03):
  • [37] Exercise and Cystic Fibrosis
    Ding, Shengguang
    Zhong, Chongjun
    PHYSICAL EXERCISE FOR HUMAN HEALTH, 2020, 1228 : 381 - 391
  • [38] Mucolytics in cystic fibrosis
    Henke, Markus O.
    Ratjen, Felix
    PAEDIATRIC RESPIRATORY REVIEWS, 2007, 8 (01) : 24 - 29
  • [39] Chronic daily respiratory care needs in people with cystic fibrosis treated with highly effective cystic fibrosis transmembrane conductance regulator modulators
    Wajda, Katherine E.
    Roesch, Erica A.
    Gifford, Alex H.
    CURRENT OPINION IN PULMONARY MEDICINE, 2023, 29 (06) : 580 - 586
  • [40] Cystic Fibrosis: Pathogenesis and Future Treatment Strategies Discussion
    Rubin
    Ratjen
    Rosenblatt
    Marshall
    Lester
    Newton
    Geller
    RESPIRATORY CARE, 2009, 54 (05) : 603 - 605